K151929

Substantially Equivalent

PERSYST 13 (P13) EEG REVIEW AND ANALYSIS SOFTWARE

Applicant: Persyst Development Corporation
Product code: OMB
Advisory panel: Neurology
Date received: 2015-07-14
Decision date: 2015-08-12
Decision: Substantially Equivalent
Clearance type: Special
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.